Health and Healthcare

Merck : MRK

All Merck Articles

1088 Articles

Chris Lange | Jan 5, 2017 at 11:05 AM EST

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a…

Paul Ausick | Jan 5, 2017 at 8:10 AM EST

How a Slimmer Procter & Gamble Might Fare in 2017

A slimmer portfolio is expected to pay off for Procter & Gamble investors as the company now focuses on 10…

Paul Ausick | Jan 3, 2017 at 4:01 PM EST

Nike, Verizon Lead DJIA Higher Tuesday

Thinkstock[cnxvideo id=”655424″ placement=”ros”]January 3, 2017: Markets opened higher Tuesday following the beginning of promised cuts to crude oil production by…

Jon C. Ogg | Dec 31, 2016 at 11:14 AM EST

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the…

Paul Ausick | Dec 28, 2016 at 4:01 PM EST

Caterpillar, Intel Sink DJIA Wednesday

December 28, 2016: Markets opened higher Wednesday but any recovery from Tuesday’s end-of-day selling failed to materialize. Trading reversed course…

Chris Lange | Dec 28, 2016 at 10:25 AM EST

Short Interest Rises in Major Pharma

The December 15 short interest data have been compared with the previous figures, and short interest increased in most of…

Paul Ausick | Dec 21, 2016 at 4:01 PM EST

Merck, Pfizer Weigh on DJIA Wednesday

December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think…

Lee Jackson | Dec 19, 2016 at 8:55 AM EST

Top Analysts Upgrades and Downgrades: Anadarko Petroleum, Bristol-Myers, Comcast, Disney, Merck and More

Monday’s top analyst upgrades, downgrades and initiations include Anadarko Petroleum, Bristol-Myers Squibb, Comcast, Walt Disney and Merck.

Jon C. Ogg | Dec 12, 2016 at 11:10 AM EST

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

At the end of each year, investors look for opportunities and safe harbors to park their money for the year…

Chris Lange | Dec 12, 2016 at 8:44 AM EST

Short Sellers Back Way Off Major Pharma Stocks

The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected…

Paul Ausick | Dec 9, 2016 at 4:01 PM EST

Pfizer, Coca-Cola Lead Dow Higher Friday

December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big…

Lee Jackson | Dec 1, 2016 at 8:10 AM EST

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for…

Paul Ausick | Nov 28, 2016 at 4:01 PM EST

Nike, Visa Lead DJIA Down on Monday

November 28, 2016: Markets opened lower Monday after a long weekend of eating and shopping. There was no economic news…

Chris Lange | Nov 28, 2016 at 7:15 AM EST

Short Sellers Hike Their Bets in Most Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest was mixed in the…

Paul Ausick | Nov 18, 2016 at 4:01 PM EST

American Express, Disney Weigh on DJIA Friday

November 18, 2016: Markets opened higher Friday but the good vibe did not last. The energy sector posted the best…

1 … 32 33 34 35 36 … 73

Merck : MRK

All Merck Articles

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

How a Slimmer Procter & Gamble Might Fare in 2017

Nike, Verizon Lead DJIA Higher Tuesday

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Caterpillar, Intel Sink DJIA Wednesday

Short Interest Rises in Major Pharma

Merck, Pfizer Weigh on DJIA Wednesday

Top Analysts Upgrades and Downgrades: Anadarko Petroleum, Bristol-Myers, Comcast, Disney, Merck and More

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Pfizer, Coca-Cola Lead Dow Higher Friday

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Nike, Visa Lead DJIA Down on Monday

Short Sellers Hike Their Bets in Most Major Pharma Stocks

American Express, Disney Weigh on DJIA Friday

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

Merck : MRK

All Merck Articles

2017 Bull-Bear Case for Health Care: J&J, Merck, Pfizer, UnitedHealth

How a Slimmer Procter & Gamble Might Fare in 2017

Nike, Verizon Lead DJIA Higher Tuesday

Meet the 2017 Dogs of the Dow: Massive Dividends and Expected Upside

Caterpillar, Intel Sink DJIA Wednesday

Short Interest Rises in Major Pharma

Merck, Pfizer Weigh on DJIA Wednesday

Top Analysts Upgrades and Downgrades: Anadarko Petroleum, Bristol-Myers, Comcast, Disney, Merck and More

Meet the Preliminary 2017 Dogs of the Dow for Massive Dividends

Short Sellers Back Way Off Major Pharma Stocks

Pfizer, Coca-Cola Lead Dow Higher Friday

Analyst’s Top Pharmaceutical Buys Offer Big Dividends and Growth Potential

Nike, Visa Lead DJIA Down on Monday

Short Sellers Hike Their Bets in Most Major Pharma Stocks

American Express, Disney Weigh on DJIA Friday

“Grow a Spine”: All-In Podcast Pushes Back on AI Regulation and Calls PayPal’s $60 Takeover Offer Just an Opening Bid

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here’s How to Retire There at 62 Without Touching Your Savings

Featured Reads

The $1.2 Million 401(k) Tax Trap That Costs Retirees 40% in Hidden Surcharges

$3,000 a Month in Sun City: Here's How to Retire There at 62 Without Touching Your Savings